These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12117320)

  • 1. Feasibility and limitations of the rat model by C6 gliomas implanted at the subcutaneous region.
    Watanabe K; Sakamoto M; Somiya M; Amin MR; Kamitani H; Watanabe T
    Neurol Res; 2002 Jul; 24(5):485-90. PubMed ID: 12117320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of experimental glioma models at the intrinsic brainstem region of the rats.
    Sho A; Kondo S; Kamitani H; Otake M; Watanabe T
    Neurol Res; 2007 Jan; 29(1):36-42. PubMed ID: 17427273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rat glioblastoma model with diffuse leptomeningeal gliomatosis induced by intracarotid injection of C6 glioma cells.
    Wasita B; Kamitani H; Kinoshita Y; Mamun MH; Watanabe T
    Neurol Res; 2009 Jun; 31(5):453-62. PubMed ID: 19309540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model.
    Kaiser MG; Parsa AT; Fine RL; Hall JS; Chakrabarti I; Bruce JN
    Neurosurgery; 2000 Dec; 47(6):1391-8; discussion 1398-9. PubMed ID: 11126910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth control of C6 glioma in vivo by nerve growth factor.
    Kimura S; Yoshino A; Katayama Y; Watanabe T; Fukushima T
    J Neurooncol; 2002 Sep; 59(3):199-205. PubMed ID: 12241115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invading C6 glioma cells maintaining tumorigenicity.
    Chicoine MR; Silbergeld DL
    J Neurosurg; 1995 Oct; 83(4):665-71. PubMed ID: 7674017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous regression of experimental gliomas--an immunohistochemical and MRI study of the C6 glioma spheroid implantation model.
    Vince GH; Bendszus M; Schweitzer T; Goldbrunner RH; Hildebrandt S; Tilgner J; Klein R; Solymosi L; Christian Tonn J; Roosen K
    Exp Neurol; 2004 Dec; 190(2):478-85. PubMed ID: 15530886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced tumorigenicity of rat glioma cells in the brain when mediated by hygromycin phosphotransferase.
    Hormigo A; Friedlander DR; Brittis PA; Zagzag D; Grumet M
    J Neurosurg; 2001 Apr; 94(4):596-604. PubMed ID: 11302658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model.
    Morrone FB; Oliveira DL; Gamermann P; Stella J; Wofchuk S; Wink MR; Meurer L; Edelweiss MI; Lenz G; Battastini AM
    BMC Cancer; 2006 Sep; 6():226. PubMed ID: 16995949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors.
    Saleh M; Wiegmans A; Malone Q; Stylli SS; Kaye AH
    J Natl Cancer Inst; 1999 Mar; 91(5):438-45. PubMed ID: 10070943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment of a Wistar rat model bearing brain glioma C6 cells and its experimental application].
    Yi LH; Fu XP; Li AM; Yan RM
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Feb; 31(2):277-9. PubMed ID: 21354911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can experimental models of rodent implantation glioma be improved? A study of pure and mixed glioma cell line tumours.
    Whittle IR; Macarthur DC; Malcolm GP; Li M; Washington K; Ironside JW
    J Neurooncol; 1998 Feb; 36(3):231-42. PubMed ID: 9524101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitations of the C6/Wistar rat intracerebral glioma model: implications for evaluating immunotherapy.
    Parsa AT; Chakrabarti I; Hurley PT; Chi JH; Hall JS; Kaiser MG; Bruce JN
    Neurosurgery; 2000 Oct; 47(4):993-9; discussion 999-1000. PubMed ID: 11014444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescent diagnosis and photodynamic therapy for C6 glioma in combination with antiangiogenic therapy in subcutaneous and intracranial tumor models.
    Tzerkovsky DA; Osharin VV; Istomin YP; Alexandrova EN; Vozmitel MA
    Exp Oncol; 2014 Jun; 36(2):85-9. PubMed ID: 24980761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of in vitro and in vivo effect of docosahexaenoic acid on rat C6 glioma.
    Nasrollahzadeh J; Siassi F; Doosti M; Eshraghian MR
    J Exp Ther Oncol; 2009; 8(2):95-103. PubMed ID: 20192116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological characteristics and markers of proliferation and differentiation in rat brain with experimental glioma.
    Ristić S; Mirić M; Jović S; Ristić S; Karić J
    Vojnosanit Pregl; 2014 Sep; 71(9):828-32. PubMed ID: 25282780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effects of erucylphosphocholine on brain tumor cells in vitro and in vivo.
    Erdlenbruch B; Jendrossek V; Marx M; Hunold A; Eibl H; Lakomek M
    Anticancer Res; 1998; 18(4A):2551-7. PubMed ID: 9703909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a xenograft glioma model in mouse brain.
    Kaye AH; Morstyn G; Gardner I; Pyke K
    Cancer Res; 1986 Mar; 46(3):1367-73. PubMed ID: 3943101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a rat C6 brain tumor model.
    Zhang X; Wu J; Gao D; Fei Z; Qu Y; Jing J
    Chin Med J (Engl); 2002 Mar; 115(3):455-7. PubMed ID: 11940388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the antiangiogenic effect of Kringle 1-5 in a rat glioma model.
    Lin YL; Tsai MJ; Lo MJ; Chang SE; Shih YH; Lee MJ; Kuo HS; Kuo WC; Huang WC; Cheng H; Huang MC
    Neurosurgery; 2012 Feb; 70(2):479-89; discussion 489-90. PubMed ID: 21796002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.